Active surveillance with selective delayed intervention: walking the line between overtreatment for indolent disease and undertreatment for aggressive disease.

The Canadian journal of urology

Volumn 12 Suppl 1, Issue , 2005, Pages

  Klotz, Laurence H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; CANCER INVASION; CANCER STAGING; CLINICAL TRIAL; DISEASE COURSE; HUMAN; IMMUNOHISTOCHEMISTRY; INTERVENTION STUDY; MALE; METHODOLOGY; MIDDLE AGED; MONITORING; MORTALITY; NEEDLE BIOPSY; OBSERVATION; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; PROSTATE TUMOR; RISK MANAGEMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL; TIME;

AGED; BIOPSY, NEEDLE; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERVENTION STUDIES; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OBSERVATION; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK MANAGEMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 18244389993     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)